BCL2 and cervical carcinoma: The strong staining of Bcl‐2, VEGFα, and Ki‐67 was present in 92.6%, 91.6%, and 94.6%, respectively, in the cervical cancer sample (Tables 2 and 3, and Figure 2A–C).